Key Findings: In rats, cannabigerol (CBG) produced potent inflammatory effects in this model of diabetic kidney disease (DKD) development.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): Poland
Year of Pub: 2025
Cannabinoids Studied: Cannabigerol (CBG)
Phytocannabinoid Source: Not Applicable
Ligands Studied: Pro-inflammatory cytokines
Route of Administration: Oral (Ingestion)
Citation: Stepaniuk A, Sztolsztener K, Konstantynowicz-Nowicka K, Harasim-Symbor E, Bielawiec P, Chabowski A. The Identification of Novel Anti-Inflammatory Effects of Cannabigerol in the Kidney Tissue of Rats Subjected to a High-Fat High-Sucrose Diet. Int J Mol Sci. 2025 Mar 28;26(7):3114. doi: 10.3390/ijms26073114. PMID: 40243749; PMCID: PMC11988375.